Suppr超能文献

细菌对氯霉素和氟苯尼考耐药性的分子基础。

Molecular basis of bacterial resistance to chloramphenicol and florfenicol.

作者信息

Schwarz Stefan, Kehrenberg Corinna, Doublet Benoît, Cloeckaert Axel

机构信息

Institut für Tierzucht, Bundesforschungsanstalt für Landwirtschaft (FAL), Höltystrasse 10, 31535 Neustadt-Mariensee, Germany.

出版信息

FEMS Microbiol Rev. 2004 Nov;28(5):519-42. doi: 10.1016/j.femsre.2004.04.001.

Abstract

Chloramphenicol (Cm) and its fluorinated derivative florfenicol (Ff) represent highly potent inhibitors of bacterial protein biosynthesis. As a consequence of the use of Cm in human and veterinary medicine, bacterial pathogens of various species and genera have developed and/or acquired Cm resistance. Ff is solely used in veterinary medicine and has been introduced into clinical use in the mid-1990s. Of the Cm resistance genes known to date, only a small number also mediates resistance to Ff. In this review, we present an overview of the different mechanisms responsible for resistance to Cm and Ff with particular focus on the two different types of chloramphenicol acetyltransferases (CATs), specific exporters and multidrug transporters. Phylogenetic trees of the different CAT proteins and exporter proteins were constructed on the basis of a multisequence alignment. Moreover, information is provided on the mobile genetic elements carrying Cm or Cm/Ff resistance genes to provide a basis for the understanding of the distribution and the spread of Cm resistance--even in the absence of a selective pressure imposed by the use of Cm or Ff.

摘要

氯霉素(Cm)及其氟化衍生物氟苯尼考(Ff)是细菌蛋白质生物合成的高效抑制剂。由于在人类医学和兽医学中使用氯霉素,各种属的细菌病原体已产生和/或获得了对氯霉素的抗性。氟苯尼考仅用于兽医学,并于20世纪90年代中期引入临床使用。在迄今已知的氯霉素抗性基因中,只有少数也介导对氟苯尼考的抗性。在本综述中,我们概述了对氯霉素和氟苯尼考产生抗性的不同机制,特别关注两种不同类型的氯霉素乙酰转移酶(CATs)、特定的转运蛋白和多药转运体。基于多序列比对构建了不同CAT蛋白和转运蛋白的系统发育树。此外,还提供了携带氯霉素或氯霉素/氟苯尼考抗性基因的可移动遗传元件的信息,以便为理解氯霉素抗性的分布和传播提供基础——即使在没有使用氯霉素或氟苯尼考所施加的选择压力的情况下。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验